MedPath

Evaluation of a patient oriented deprescribing strategy to achieve reduction of oversupply of proton pump inhibitors (PPI)

Not Applicable
Conditions
medical counseling of patients regarding the reduction of oversupply of proton pump inhibitors (PPI)
Registration Number
DRKS00016364
Lead Sponsor
Abteilung für Allgemeinmedizin, Präventive und Rehabilitative Medizin Philipps-Universität Marburg
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
2440
Inclusion Criteria

longterm PPI prescription of at least 6 months

Exclusion Criteria

reluctance to participate, lack of German fluency, cognitive limitations that hinder study education and comprehension, mere home visit patients (e.g. practice visits are not possible due to frailty)

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Cumulative DDD-PPI (Defined Daily Doses) per study patient per practice in the following 6 months after first counsel (training of the general practitioner and following counsel with arriba-PPI)
Secondary Outcome Measures
NameTimeMethod
Cumulative DDD-PPI per study patient per practice in the following 12 months after first counsel (training of the general practitioner and following counsel with arriba-PPI). <br>Ratio of PPI-patients within all patients of one practice for the last two billing quarters at 12 months after training.<br>Average cumulative DDD-PPI within all PPI-patients of one practice for the last two billing quarters at 12 months after training.
© Copyright 2025. All Rights Reserved by MedPath